Video Experimental Relacionado
Updated: Jul 9, 2026
06:03
Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis
Published on: July 12, 2011
La epidemiología del tromboembolismo venoso
1University of California, Davis, Sacramento, California, USA. rhwhite@ucdavis.edu
Circulation
|June 20, 2003
Resumen
El tromboembolismo venoso (TEV) afecta a aproximadamente 100 de cada 100,000 estadounidenses anualmente, aumentando con la edad. Esta condición, que a menudo se presenta como trombosis venosa profunda o embolia pulmonar, conlleva riesgos significativos de recurrencia y mortalidad.
Área de la Ciencia:
- Epidemiología La epidemiología.
- La medicina vascular es una medicina vascular.
Sus antecedentes:
- La incidencia de tromboembolismo venoso (TEV) es de aproximadamente 100 por cada 100.000 personas-año en los EE.UU..
- El riesgo de TEV aumenta con la edad, de menos de 5 casos por cada 100.000 en menores de 15 años a 500 por cada 100.000 en personas de 80 años.
- La TEV se presenta como trombosis venosa profunda (TVP) en dos tercios de los casos y embolia pulmonar (EP) en un tercio.
Objetivo del estudio:
- Resumir la epidemiología y las características clínicas del primer tromboembolismo venoso (TEV).
Principales métodos:
- Análisis retrospectivo de la incidencia y los resultados de TEV.
- Examen de los factores de riesgo demográficos, clínicos y temporales para la TEV.
Principales resultados:
- La recurrencia de TEV ocurre en aproximadamente el 7% de los pacientes dentro de los 6 meses a pesar de la anticoagulación.
- Las tasas de mortalidad dentro de un mes del diagnóstico son del 6% para la TVP y del 12% para la EP.
- Se observa una mayor incidencia de TEV en invierno, entre caucásicos y afroamericanos, y en pacientes con cáncer o enfermedades cardiovasculares.
Conclusiones:
- La TEV es un problema de salud importante con tasas notables de recurrencia y mortalidad.
- Los factores de riesgo incluyen la edad avanzada, el origen étnico y las comorbilidades.
- La TEV idiopática representa entre el 25 y el 50% de los eventos por primera vez.
Videos de Conceptos Relacionados
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...